For Psychedelics, US FDA Is Open To Creative Thinking But Firm On Approval Standards - Pink Sheet Citeline
Flexible thinking and rigorous standards will both be needed to develop psychedelics as drug therapies in order to surmount the many complicating factors, from unique ‘set and setting’ aspects to functional unblinding, speakers at Reagan-Udall Foundation meeting agree.